QS Initiative Gains Significance In 2003 Budget Crunch – McClellan
This article was originally published in The Gray Sheet
Executive Summary
FDA's quality systems improvement initiative is the vehicle by which Commissioner Mark McClellan hopes to leverage substantial device review reforms from CDRH's FY 2003 appropriation of $208 mil
You may also be interested in...
PMA Slowdown To Persist In ’04, McClellan Says; User Fee Hikes To Follow?
FDA expects the rate of new product applications to continue declining for the foreseeable future, despite a series of review cycle improvement initiatives begun in January
PMA Slowdown To Persist In ’04, McClellan Says; User Fee Hikes To Follow?
FDA expects the rate of new product applications to continue declining for the foreseeable future, despite a series of review cycle improvement initiatives begun in January
IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests